Dr. Reddy's Laboratories (DRREDDY) — Announcement

Dr. Reddy's Laboratories disclosed a tax notice from the Hyderabad Income Tax Authority regarding a potential reassessment of income for FY 2019-20 under Section 148 of the Income Tax Act, linked to the 2022 merger with Dr. Reddy's Holding Limited. The company states there is no material impact on financials or operations, and emphasizes the merger complied with all legal requirements including tax laws. A proposed demand of ₹239.58 crores was quantified in the notice, though the firm is reviewing the order and will act appropriately.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How does this announcement affect Dr. Reddy's Laboratories Limited's outlook?" "What did Dr. Reddy's Laboratories Limited announce on 31 May 2025?" "Is this positive or negative for DRREDDY?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 31 May 2025

APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results COALINDIA Coal India Limited Offer Document AMBUJACEM Ambuja Cements Limited Annual Report AMBUJACEM Ambuja Cements Limited Annual Report APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results MARICO Marico Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.